https://www.selleckchem.com/pr....oducts/Vorinostat-sa
The 30-day mortality was 0%. The median length of stay was 8.6 days (IQR 5-11). Median overall survival following LR was 36.8 months compared to 9.2 months in patients with metachronous liver metastasis with chemotherapy (p=0007). Liver resection for metachronous PDAC metastasis is safe and feasible in selected patients. To address general applicability and to find factors for patient selection, larger trials are urgently warranted. Liver resection for metachronous PDAC metastasis is safe and feasible in selected patients. To ad
Like
Comment
Share
